Perbedaan Koka Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Koka Indonesia Tbk. diperdagangkan di Rp191 (kapitalisasi pasar 560,82 M, volume 24 jam 16 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Koka Indonesia Tbk. jauh lebih besar — sekitar 5,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KOKA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 560,82 M | 104,4 M |
Volume | 16 jt | — |
Lot | 160,01 rb | — |
Perputaran | 3,06 M | — |
Harga Rata-rata | 191,37 | — |
Nilai Transaksi | 3,06 M | — |
Harga Ekuilibrium Indikatif | 191 | — |
Volume Ekuilibrium Indikatif | 5,06 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Koka Indonesia Tbk (the Entity) was established in Jakarta, based on Notarial Deed of Innovani Damanik, S.H., M.Kn., No. 45, dated June 21, 2011. The Entity started commercial operations in 2012.
Selengkapnya di halaman KOKA →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →